White label ELPA - ClinicalTrials.eu

Study of Vosoritide Safety and Effectiveness in Infants and Young Children (0 to 36 months) with Hypochondroplasia

Recruiting

2 1 1
Investigated diseases:
- Hypochondroplasia
Investigated drugs:
- Vosoritide
Study comparing diclofenac, orphenadrine and paracetamol combination versus diclofenac alone and orphenadrine-paracetamol combination in patients with acute low back pain

Recruiting

3 1 1
Investigated drugs:
- Paracetamol
Study of Obinutuzumab treatment for patients with non-infectious cryoglobulinemia vasculitis who did not respond to or cannot tolerate Rituximab

Recruiting

2 1 1 1
Investigated diseases:
- Cryoglobulinaemia
Investigated drugs:
- Obinutuzumab
Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

Recruiting

3 1 1 1
Investigated diseases:
- Endotracheal intubation
Investigated drugs:
- Remifentanil Hydrochloride
- Rocuronium Bromide
Study of cemiplimab treatment after surgery in patients with stage II-IIIA non-small cell lung cancer who have not received chemotherapy and have PD-L1 expression of 1% or higher

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Cemiplimab
+1
Study comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection

Recruiting

2 1 1
Investigated diseases:
- Chronic hepatitis B
Investigated drugs:
- ALG-000184
- Tenofovir Disoproxil
Study of TYRA-300-B01 tablets in patients with low grade, intermediate risk non-muscle invasive bladder cancer who have FGFR3 gene changes

Recruiting

2 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- Tyra-300-B01
Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Recruiting

3 1 1
Investigated diseases:
- Dyslipidaemia
Investigated drugs:
- Obicetrapib
- Bempedoic Acid
+1
Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
+9
Evaluation of pembrolizumab and bevacizumab in patients with metastatic cervical cancer

Recruiting

3 1 1 1
Investigated diseases:
- Cervix carcinoma
Investigated drugs:
- Bevacizumab
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies